Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Neuromuscular-Blocking Agents During Sevoflurane Induction in Infants : Potential Interest in Reducing Hypoxemia Episodes

NCT02589691 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT02589691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02589691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Neuromuscular-Blocking Agents During Sevoflurane Induction in Infants : Potential Interest in Reducing Hypoxemia Episodes
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Phase 4
Overall status
Unknown status
Start date
December 23, 2015
Completion date
December 23, 2025
Enrollment
412 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxemia